Delfina Raises $17M to Transform Maternal Health with AI-Powered Proactive Care
Delfina筹集1700万美元，惠阳保姆13825404095通过人工智能支持的主动护理改变孕产妇健康
SAN FRANCISCO, January 28, 2025-- Delfina Care Inc. (Delfina), a healthcare technology company solving the maternal health crisis with an AI-powered care system, today announced the successful close of its $17 million Series A funding round led by U.S. Venture Partners (USVP). The investment underscores Delfina's rapid progress in its mission to transform pregnancy care by delivering equitable access to individualized insights and integrated systems that improve health outcomes..
旧金山，2025年1月28日——Delfina Care Inc.（Delfina）是一家利用人工智能医疗系统解决孕产妇健康危机的医疗技术公司，今天宣布成功结束由美国风险投资伙伴（USVP）牵头的1700万美元a轮融资。。。
Addressing the Maternal Health Crisis
应对孕产妇健康危机
The United States is facing a maternal health crisis. In 2021, the maternal mortality rate was 32.9 deaths per 100,000 live births—more than double that of other high-income countries. Black women face a maternal mortality rate nearly three times higher than white women and a preterm birth rate 1.4 times higher.
美国正面临孕产妇健康危机。2021年，孕产妇死亡率为每10万活产32.9人死亡，是其他高收入国家的两倍多。黑人女性的孕产妇死亡率几乎是白人女性的三倍，早产率是白人女性的1.4倍。
Tackling this crisis requires better access to quality maternal care and addressing social determinants of health..
应对这场危机需要更好地获得优质孕产妇护理，并解决健康的社会决定因素。。
Delfina's AI-powered maternal health platform addresses these challenges by combining award-winning predictive analytics, tailored interventions, and closed-loop connection (through data) between the patient and their primary prenatal care provider to improve outcomes for moms and babies.
Delfina的人工智能孕产妇保健平台通过结合屡获殊荣的预测分析、量身定制的干预措施以及患者与其初级产前保健提供者之间的闭环连接（通过数据）来解决这些挑战，以改善母亲和婴儿的结局。
Proven Impact
行之有效的影响
Delfina's evidence-based approach has demonstrated measurable success for maternal and infant health. Delfina partners have observed reductions in preterm births, NICU admissions, hypertensive disorders, and gestational diabetes—the leading causes of preterm births, maternal morbidity, and mortality.
德尔菲纳的循证方法在母婴健康方面取得了可衡量的成功。Delfina partners观察到早产，NICU入院，高血压疾病和妊娠糖尿病的减少，这是早产，孕产妇发病率和死亡率的主要原因。
Based on these improved outcomes, Delfina guarantees 3X cost savings for health plans..
基于这些改进的结果，德尔菲纳保证为健康计划节省3倍的成本。。
Fueling Expansion and Innovation
推动扩张和创新
'This funding marks a significant milestone in Delfina's fulfillment of our mission to solve the national maternal health crisis,' said Senan Ebrahim, MD, PhD, CEO and Founder of Delfina. 'We are grateful for the support of our investors and partners who share our commitment to improving outcomes for moms and babies.
Delfina首席执行官兼创始人塞南·易卜拉欣（SenanEbrahim）医学博士说，这笔资金标志着Delfina完成我们解决全国孕产妇健康危机的使命的一个重要里程碑我们感谢投资者和合作伙伴的支持，他们与我们一样致力于改善母亲和婴儿的结局。
With this capital, Delfina will accelerate serving diverse populations, scale our impact nationally, and evolve our market-leading AI-powered predictive technology to continue delivering proven results for our partners nationwide.'.
有了这笔资金，德尔菲纳将加快为不同人群提供服务，扩大我们在全国的影响力，并发展我们市场领先的人工智能预测技术，以继续为我们在全国的合作伙伴提供经验证的结果。”。
'Since we transformed our practice with Delfina Care, we have seen the positive impact on our pregnant patients' care every day,' said Fatimah Lalani, DO, Chief Medical Officer of HOPE Clinic in Houston, Texas. 'We see many patients whose cardiovascular and metabolic challenges we can now proactively manage thanks to Delfina's insights.
德克萨斯州休斯顿霍普诊所（HOPE Clinic）首席医疗官法蒂玛·拉拉拉尼（FatimahLalani）说，自从我们用德尔菲纳护理（DelfinaCare）改变了我们的做法以来，我们每天都看到了对怀孕患者护理的积极影响由于Delfina的见解，我们看到许多患者的心血管和代谢挑战现在可以积极应对。
Our clinicians have been empowered by Delfina's system to efficiently provide a new level of proactive care for healthy pregnancy outcomes.'.
。
Investor Confidence
投资者信心
The Series A round was led by U.S. Venture Partners (USVP) and included participation from new investors ARTIS Ventures, Mayo Clinic, and Tokio Marine Future Fund. Delfina's existing investors also participated in the round, including Story Ventures, SemperVirens, Bread and Butter Ventures, Boutique Ventures, and Chelsea Clinton's Metrodora Ventures..
A轮由美国风险投资合作伙伴（USVP）牵头，新投资者ARTIS Ventures、Mayo Clinic和Tokio Marine Future Fund也参与了这一轮。德尔菲纳的现有投资者也参与了这轮投资，包括Story Ventures、SemperVirens、面包和黄油风险投资、精品风险投资和切尔西·克林顿的Metrodora风险投资。。
'Delfina's care system is built on the most advanced machine learning technology that creates the most measurable impact for our healthcare system,' said Dafina Toncheva, USVP General Partner. 'We are excited to see the lifesaving application of this cutting-edge tech to maternal health. We are thrilled to join Delfina in delivering the future of pregnancy care to all families.'.
USVP普通合伙人达芬娜·托切娃（DafinaToncheva）说，德尔菲纳（Delfina）的医疗保健系统建立在最先进的机器学习技术之上，为我们的医疗保健系统产生了最可衡量的影响我们很高兴看到这项尖端技术在产妇健康方面的救生应用。我们很高兴能与Delfina一起为所有家庭提供未来的妊娠护理。”。
About Delfina
关于Delfina
Delfina is transforming pregnancy care by partnering with payors, providers, and community organizations to deliver equitable, data-driven maternal health support. Through its innovative platform, Delfina empowers prenatal care teams with actionable insights, reducing disparities and improving outcomes for moms and babies.
Delfina正在通过与付款人、提供者和社区组织合作，提供公平、数据驱动的孕产妇保健支持，从而改变孕期保健。通过其创新平台，Delfina为产前护理团队提供了可行的见解，减少了差异，改善了母亲和婴儿的结局。
To learn more about Delfina's mission and solutions, visit delfina.com..
要了解更多关于Delfina的使命和解决方案，请访问Delfina.com。。
Contact:
联系人：
Media Contact
媒体联系人
Stephanie Hubbard, Delfina, 1 4015884044, Stephanie@Delfina.com,
斯蒂芬妮·哈伯德，德尔菲娜，14015884044，Stephanie@Delfina.com，
